OptoMedic Introduces Latest Imaging Platform and AI Lung Fusion Mapping Tool
Posted on 11 Nov 2024
OptoMedic Technologies Inc. (Guangdong, China) is showcasing its latest imaging platform and AI Lung Fusion Mapping tool at MEDICA 2024.
As a high-end medical device for minimally invasive surgery, endoscopes have developed rapidly in the field of 3D, 4K, and fluorescence-subdivided technologies in the international arena in the past decade, but there has been a lack of endoscopic products that integrate these three technologies. The Stellar 4K, 2D+3D, NIR/ICG+MB all-in-one platform presented at this year’s MEDICA integrates 4K, 3D, and fluorescence in an all-in-one system to meet the complete needs of clinical operations and deliver the highest standard of endoscopic technology. Based on extremely clear 4K white light and extremely sensitive 4K fluorescence, the STELLAR system has pioneered 4K optical 3D technology, bringing an immersive 3D experience to surgeons.
OptoMedic’s 4K optical 3D technology, from the dual-channel optical 3D laparoscope that can be sterilized by high temperature and high pressure, to the world's smallest 4K3D camera (only weighs 200g) and the dual-channel 4K image processing control unit, is self-developed and truly innovative. This technological innovation brings extremely clear 4K images, extremely realistic visual restoration, and comfort without dizziness to 3D endoscopic surgery. At MEDICA 2024, OptoMedic is also demonstrating its groundbreaking real-time lung tumor and nodule visualization technique for lung surgery, utilizing the company’s 3D Reconstruction Workstation and endoscopic NIR/ICG imaging system. OptoMedic’s revolutionary 3D Reconstruction Workstation integrated with real-time endoscopic imaging ushers in the future of pulmonary surgery. This forward-looking solution, which combines 3D reconstruction, ICG perfusion simulation, and real-time surgical mapping, is expected to illuminate the future of lung nodule treatment.
Related Links:
OptoMedic Technologies Inc.
